Evidence map›Paper›PMID 35408570›Full record

ArticleMolecules (Basel, Switzerland)2022

Synthesis and Anti-

Fanny Mathias, Youssef Kabri, Damien Brun, Nicolas Primas, Carole Di Giorgio, Patrice Vanelle

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Tropical medicine and infectious disease · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fanny MathiasEquipe Pharmaco-Chimie Radicalaire, CNRS, ICR UMR 7273, Faculté de Pharmacie, Aix Marseille University, 27 Boulevard Jean Moulin, CS30064, CEDEX 05, 13385 Marseille, France.
Youssef KabriEquipe Pharmaco-Chimie Radicalaire, CNRS, ICR UMR 7273, Faculté de Pharmacie, Aix Marseille University, 27 Boulevard Jean Moulin, CS30064, CEDEX 05, 13385 Marseille, France.
Damien BrunEquipe Pharmaco-Chimie Radicalaire, CNRS, ICR UMR 7273, Faculté de Pharmacie, Aix Marseille University, 27 Boulevard Jean Moulin, CS30064, CEDEX 05, 13385 Marseille, France.
Nicolas PrimasEquipe Pharmaco-Chimie Radicalaire, CNRS, ICR UMR 7273, Faculté de Pharmacie, Aix Marseille University, 27 Boulevard Jean Moulin, CS30064, CEDEX 05, 13385 Marseille, France.ORCID 0000-0002-6713-6039
Carole Di GiorgioLaboratoire de Mutagénèse Environnementale, CNRS, IRD, Aix Marseille University, IMBE UMR 7263, Avignon University, 13385 Marseille, France.
Patrice VanelleEquipe Pharmaco-Chimie Radicalaire, CNRS, ICR UMR 7273, Faculté de Pharmacie, Aix Marseille University, 27 Boulevard Jean Moulin, CS30064, CEDEX 05, 13385 Marseille, France.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human American trypanosomiasis, called Chagas disease, caused by

Indexed as

Chagas DiseaseTrypanocidal AgentsTrypanosoma cruziAnimalsCricetinaeCricetulusHumansPyrrolesStructure-Activity Relationship2-nitropyrrolePyrrolesTrypanocidal Agentschagas diseasenitro-heterocyclepyrroleT. cruzi

Identifiers

PMID35408570
PMCPMC9000427
OpenAlexW4220791624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.